MADHAV V. DHODAPKAR, MBBS, a world-renowned expert in cancer immunology and translational immunotherapy, joined Winship Cancer Institute of Emory University as Director of the new Winship Center for Cancer Immunology. He has been appointed as the Anise McDaniel Brock Chair, Georgia Research Alliance Eminent Scholar in Cancer Innovation, as well as Professor in the Department of Hematology and Medical Oncology in the Emory School of Medicine.
Madhav V. Dhodapkar, MBBS
For the past decade, Dr. Dhodapkar has served as Chief of Hematology at the Arthur H. and Isabel Bunker Professor of Medicine and Professor of Immunobiology at Yale University School of Medicine. An expert in the treatment of multiple myeloma, he also was Co-Director of the Cancer Immunology Program within the Yale Cancer Center. Dr. Dhodapkar is credited with helping to define the role of the immune system in controlling early cancer cells. His research focuses on how the immune system regulates the progression from precursor lesions to cancer as well as the mechanisms of treatment sensitivity and resistance to cancer immunotherapy.
Dr. Dhodapkar has authored more than 100 scientific papers and is a prior recipient of several awards, including the National Institutes of Health Director’s Transformative Research Award and the National Cancer Institute Outstanding Investigator Award in 2016. ■
